Lansdowne Partners (UK)’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-267,477
Closed -$25.7M 47
2016
Q1
$25.7M Buy
267,477
+9,698
+4% +$882K 0.2% 17
2015
Q4
$23.4M Buy
257,779
+32,764
+15% +$3.08M 0.16% 19
2015
Q3
$20.9M Buy
225,015
+22,380
+11% +$2.13M 0.18% 16
2015
Q2
$18.9M Buy
202,635
+19,572
+11% +$1.83M 0.16% 16
2015
Q1
$17.3M Buy
+183,063
New +$17M 0.16% 18

Other funds holding CME

Lansdowne Partners (UK)'s CME Position: Q2 2016 in Review

Lansdowne Partners (UK) sold out of CME Group (CME) in Q2 2016, closing a stake of 267,477 shares — an estimated $25.7M sold.

Lansdowne Partners (UK) first reported a position in CME in Q1 2015 and held it in 5 quarters. The position peaked at $25.7M in Q1 2016. 660 funds tracked by Wall St. Rank hold CME as of Q2 2016.

  • Lansdowne Partners (UK) reported no remaining CME Group position as of Q2 2016 after selling out during the quarter.
  • Lansdowne Partners (UK) sold 267,477 CME Group shares in Q2 2016, an estimated $25.7M.
  • Lansdowne Partners (UK) first reported a position in CME Group in Q1 2015 and held it in 5 quarters.
  • Lansdowne Partners (UK)'s CME Group position peaked at $25.7M in Q1 2016.
  • 660 funds tracked by Wall St. Rank held CME Group as of Q2 2016.

Based on Lansdowne Partners (UK)'s 13F filing for Q2 2016, filed 15 Aug 2016.